Elbit proposes to complete purchase of Elscint
This article was originally published in Clinica
Executive Summary
Elbit Medical Imaging, the holding company for Elscint, wants to buy up all Elscint shares in an offer worth about $99 million. Elbit already holds a 57% stake in Elscint, and has offered stockholders $14 a share, a 21% premium over the closing price registered on the New York Stock Exchange before the proposal was made on February 17.
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.